MedTrace Logo

Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury

NCT00631839 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2008-10-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate clinical, dosimetrical, functional, biological and genetic factors in predicting chemo-radiotherapy induced lung and esophagus injury.

Conditions

  • Thoracic Neoplasms

Interventions

RADIATION

Thoracic 3-D Conformal Radiotherapy

Thoracic RT tailored for each patient, about 60Gy (NSCLC) or 55Gy (SCLC) with photon energies \>=6MV.

Sponsors & Collaborators

  • Shanghai Cancer Hospital, China

    lead OTHER

Principal Investigators

  • Min Fan, MD · Fudan University Cancer Hospital, Department of Radiation Oncology

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2006-01-31
Completion
2008-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00631839 on ClinicalTrials.gov